Health, Fitness,Dite plan, health tips,athletic club,crunch fitness,fitness studio,lose weight,fitness world,mens health,aerobic,personal trainer,lifetime fitness,nutrition,workout,fitness first,weight loss,how to lose weight,exercise,24 hour fitness,

07/31/21

breast cancer awareness ribbonBreast cancer rates dropped by half in tandem with the discontinuation of hormone replacement therapy, according to a study published online in the Journal of the National Cancer Institute. The study was reported in the Telegraph in the United Kingdom.

The Telegraph said:

"Dr Prithwish De, of the Canadian Cancer Society, and colleagues, found that use of HRT dropped from 12.7 per cent in 2002 to 4.9 per cent in 2004.

During the same period breast cancer rates dropped by 9.6 per cent even though the same number of women were having mammography tests.

Between 2004 and 2006 use of HRT remained stable at around five per cent of women aged 50 to 59 but breast cancer rates began to increase again.

Dr De wrote: 'The results support the hypothesised link between the use of hormone replacement therapy and invasive breast cancer incidence and indicate that the sharp decline in breast cancer incidence in 2002 is likely explained by the concurrent decline in the use of hormone replacement therapy among Canadian women.'"

The study's authors said these numbers support existing evidence of the link between HRT and breast cancer.



from Articles : Hormones, Aging https://ift.tt/13bQkWb
via IFTTT

Mice lacking the insulin receptor substrate are more resistant to aging than normal mice, according to University College London researchers.

The finding further confirms the link between insulin signaling pathways and aging, and may have implications on aging in humans.

In the study, mice were engineered to lack either insulin receptor substrate IRS-1 or IRS-2, both proteins that are activated by the hormone insulin, which regulates glucose and fat metabolism. Compared with normal mice, the mice lacking IRS-1 had:

  • A 20 percent increase in their average lifespan (30 percent for female mice)
  • Better health as they aged
In contrast, mice lacking IRS-2 had shorter lives than normal mice, and developed signs of obesity and type 2 diabetes. 

Sources:


from Articles : Hormones, Aging https://ift.tt/2h6W0yN
via IFTTT

Despite widespread publicity, the 2002 landmark study on the potential dangers of hormone therapy for postmenopausal women is completely unknown to most women. 

New research from the Stanford University School of Medicine discovered that only 29 percent of the women surveyed knew anything about the study two years later. Additionally, only 40 percent of the women were able to identify possible risks and benefits linked to hormone therapy. 

Hormone therapy is used to ease your symptoms of menopause, but has also been widely prescribed for preventive purposes, based in part on earlier observational studies that had suggested it could help protect women against heart disease, weak bones, and dementia. 

In July 2002, the Women's Health Initiative (WHI) abruptly ended its combination of estrogen and progestin therapy study, as their data discovered higher rates of breast cancer, heart attacks, strokes, and blood clots in the population taking the hormones, compared to those taking placebos. 

Later, in April 2004, WHI also halted the portion of the study for estrogen-only therapy, after finding the hormone did not offer any protective heart disease prevention, but rather increased your risk of stroke and blood clots. 

The WHI findings triggered enormous changes in the use of hormone therapy, and prescriptions had dropped 38 percent by 2003. 

Senior author Randall Stafford, MD, PhD, said their latest survey indicates there's a huge problem in communicating crucial health information to patients effectively, which in turn is indicative of an even larger problem – ensuring that people can make informed decisions about their medical care. 

Menopause April 10, 2007

Women's Health Initiative June 21, 2007

WHI March 2, 2007 (The Estrogen-Alone Study Links)

Women's Health Initiative (The Estrogen-Plus-Progestin Study Links)

Eurekalert September 18, 2007



from Articles : Hormones, Aging https://ift.tt/38s6otU
via IFTTT

Many consumers have long known their favorite lotions and sunscreens contained parabens, or synthetic chemicals used as preservatives. But with more and more products being touted as “paraben-free," many are now wondering, "What, exactly, are parabens, and are they dangerous?"

Parabens, which inhibit the growth of bacteria, yeast, and molds, have been used in personal-care products like shampoos, conditioners, deodorants, and sunscreens for years, allowing these products to survive for months, or years, during shipping and on store shelves.

Studies have now shown that parabens mimic the activity of the hormone estrogen, which is associated with certain forms of breast cancer.

Organic Consumers Association September 4, 2007

 



from Articles : Hormones, Aging https://ift.tt/2RBQkQJ
via IFTTT

Scientists have identified a natural barrier to the regeneration of the inner ear's sensory cells, which are lost in hearing and balance disorders. Overcoming this barrier may be a first step in returning inner ear cells to a newborn-like state that's primed for regeneration, as described in a new study. The study suggests new gene engineering approaches that could be used to channel some of the same regenerative capability present in embryonic inner ear cells.

from Top Health News -- ScienceDaily https://ift.tt/3zViGqa

MKRdezign

Contact Form

Name

Email *

Message *

Powered by Blogger.
Javascript DisablePlease Enable Javascript To See All Widget